home / stock / vvos / vvos news

VVOS News and Press, Vivos Therapeutics Inc. From 05/11/21

Stock Information
Company Name: Vivos Therapeutics Inc.
Stock Symbol: VVOS
Market: NASDAQ
Website: vivoslife.com
Menu
VVOS VVOS Quote VVOS Short VVOS News VVOS Articles VVOS Message Board
Get VVOS Alerts

News, Short Squeeze, Breakout and More Instantly...
VVOS - Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

HIGHLANDS RANCH, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-mo...
VVOS - Vivos Therapeutics prices $24M follow-on offering

Vivos Therapeutics (VVOS) has priced its follow-on public offering of 4M shares of common stock at $6.00/share, for expected gross proceeds of $24M.Underwriters' over-allotment is an additional 600K shares. Roth Capital Partners is acting as sole book-running manager. National Securities Corp...

VVOS - Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering

HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-mo...

VVOS - BioMedNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Appoints Widely Acclaimed Leader as New Medical Director of Clinical Education

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), today announced the appointment ...
VVOS - Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education

HIGHLANDS RANCH, Colo., April 14, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-diso...

VVOS - Investing in Sleep Apnea Companies

In this episode of Industry Focus: Wildcard , join Motley Fool contributor Brian Feroldi and host Emily Flippen as they talk about three companies trying to treat sleep apnea: ResMed (NYSE: RMD) , Inspire Medical (NYSE: INSP) , and Vivos Therapeutics (NASDAQ: V...

VVOS - Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers

Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%,...
VVOS - TSLA, NVTA, CHPT and NNOX among premarket gainers

Nano-X Imaging (NNOX) +68% as FDA OKs 510(k) for Single Source Nanox.ARC Digital X-Ray.Chembio Diagnostics (CEMI) +48%.NanoVibronix (NAOV) +24%.Leaf Group Ltd. (LEAF) +19% on being acquired by Graham Holdings for $8.50 per share.dMY Technology Group (DMYD) +19%.Hoth Therapeutics (HO...

VVOS - Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service

HIGHLANDS RANCH, Colo., March 30, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-diso...

VVOS - Vivos Therapeutics EPS misses by $0.93, beats on revenue

Vivos Therapeutics (VVOS): FY GAAP EPS of -$1.40 misses by $0.93.Revenue of $13.07M (+14.7% Y/Y) beats by $0.13M.Shares +3.22%.Press Release For further details see: Vivos Therapeutics EPS misses by $0.93, beats on revenue

Previous 10 Next 10